Search Results - "Jie, Guang‐Ling"

MET amplification identified by next-generation sequencing and its clinical relevance for MET inhibitors.

Authors: Peng, Lun-Xi Jie, Guang-Ling Li, An-Na et al.

Source: Experimental Hematology & Oncology. 11/10/2021, Vol. 10 Issue 1, p1-7. 7p.

Longitudinal Plasma Proteomics-Derived Biomarkers Predict Response to MET Inhibitors for MET-Dysregulated NSCLC.

Authors: Jie, Guang-Ling Peng, Lun-Xi Zheng, Mei-Mei et al.

Source: Cancers. Jan2023, Vol. 15 Issue 1, p302. 15p.

Prognostic features and comprehensive genomic analysis of NF1 mutations in EGFR mutant lung cancer patients.

Authors: Tian, Hong‐xia Chen, Zhi‐hong Jie, Guang‐Ling et al.

Source: Cancer Medicine. Jan2023, Vol. 12 Issue 1, p396-406. 11p.